Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

October 10, 2015 3:08 AM ET


Company Overview of OSI Pharmaceuticals Inc.

Company Overview

As of May, 2013, OSI Pharmaceuticals Inc. went out of business. OSI Pharmaceuticals Inc. offers oncology drug discovery and translational research services which includes discovery of molecular targeted therapies. The company offers Tarceva, which treats non-small cell lung cancer. It develops OSI-906, a small-molecule and dual kinase inhibitor of insulin-like growth factor-1 receptor and insulin receptor for lung and ovarian cancers. The company develops OSI-027, a mammalian target of rapamycin kinase inhibitor that inhibits the kinase activity associated with the TORC1 and TORC2 complexes of mTOR. The company was formerly known as Oncogene Science Inc. and changed its name to OSI Pharmaceu...

1 Bioscience Park Drive

Farmingdale, NY 11735

United States

Founded in 1983

512 Employees





Key Executives for OSI Pharmaceuticals Inc.

OSI Pharmaceuticals Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
VSL Pharmaceuticals, Inc. United States
Athenex United States
Napo Pharmaceuticals, Inc. United States
CIBA Vision Puerto Rico, Inc. United States
Aponia Laboratories Inc. United States

Recent Private Companies Transactions

May 6, 2015
EpiTherapeutics ApS

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OSI Pharmaceuticals Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at